Respected colleagues and potential authors,
We want to announce that ReAttach Therapy International Foundation launched new journal entitled: Journal for ReAttach Therapy and Developmental Diversities (JRTDD). JRTDD is a multidisciplinary peer reviewed, international, electronic journal edited by the ReAttach Therapy International Foundation from the Netherlands. The following articles will be considered for publication: original and review articles, short report, letters to the editor, clinical experiences, survey of cases, doctoral dissertations, master of arts, editorials, rapid communications and other contributions from all the fields of reattach therapy, psychology, special education, rehabilitation, social policy, and the related sciences. The aim of the journal is to share and disseminate knowledge between all disciplines that work in the field of developmental disabilities. All articles will be critically reviewed by at least two unknown reviewers within 2 months, but longer delays are sometimes unavoidable. All manuscripts must comply with Authors Instructions. There are around 20 articles published per year. JRTDD allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. Journal for ReAttach Therapists and Developmental Diversities is devoted to the scientific study of disability and new schema therapy. The subject matter is broad and includes, but is not restricted to, findings from psychological, biological, educational, genetic, medical, psychiatric, and sociological studies, ethical, philosophical, and legal contributions that increase knowledge on the prevention and treatment of disability, and/or inform public policy and practice.
You are kindly invited to submit an article in our Journal. Please type them in Word format. Please use Times New Roman font with Font size 12. The manuscript can not exceed 20 pages or 30.000 characters (no spaces) with single paragraph A4 format including Abstract, Tables and Figures. The margins should be 2,5 cm from every side. The style of referencing is according to APA.
You should send the articles electronically via our web site. If there is any problem you can contact us on the following email: email@example.com
The dead line for sending the manuscripts is September 30th 2018.
Prof. Dr. Vladimir Trajkovski
Dear colleagues and readers,
I would like to inform you that 1st issue of the 1st volume of Journal for ReAttach Therapy and Developmental Diversities is published online (August 15, 2018). A total number of 8 papers are published. Next Issue 2 of JRTDD for the 2018 year is expected to be published until December 31st, 2018.
Accessing JRTDD Online
To view a current article which appears online, please visit http://jrtdd.com/volume1-issue-1/
You, your colleagues, and students will be able to view articles (Full-Text PDF and Online First Full-text PDF) and have unlimited access to the journal (JRTDD is an open access, international, peer reviewed journal).
Citing Articles Using the Digital Object Identifier (DOI)
When citing articles from JRTDD, we encourage you to use article’s DOI in addition to traditional citation information. This is an industry standard, a link-resolving system that allows any link to remain “persistent” even if the location of the article changes at some point in the future. Hence, when you are quoting the link for an article, you should always quote the DOI rather than the URL of our home page.
Useful Online Features for Authors
Your registration in online submission (http://jrtdd.com/submit-your-manuscript/) will enable you with continuous information connected with JRTDD. We encourage you to share publications from JRTDD platform and online registration with your colleagues. You can feel free to share every publication on social media.
We invite you to the content of the JRTDD and we think that you will consider publishing with Journal for ReAttach Therapy and Developmental Diversities.
Call for papers for Vol.1, Issue 2 is open until September 30.
Suggested topics include but are not limited to
- ReAttach Therapy,
- Neuropsychological Research,
- Medical Aspects of Disability,
- Special Education Research,
- Rehabilitation Research,
- Social Aspects of Disability,
- Master theses and PhD theses in the field,
- Book Reviews in the field.
If you have any questions or you face problems with paper submission, please feel free to contact us: firstname.lastname@example.org
ReAttach Therapy International Foundation
6367 ER Voerendaal
18 June 2018 ¦ Geneva: The World Health Organization (WHO) is today releasing its new International Classification of Diseases (ICD-11).
The ICD is the foundation for identifying health trends and statistics worldwide, and contains around 55 000 unique codes for injuries, diseases and causes of death. It provides a common language that allows health professionals to share health information across the globe.
“The ICD is a product that WHO is truly proud of,” says Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “It enables us to understand so much about what makes people get sick and die, and to take action to prevent suffering and save lives.”
ICD-11, which has been over a decade in the making, provides significant improvements on previous versions. For the first time, it is completely electronic and has a much more user-friendly format. And there has been unprecedented involvement of health care workers who have joined collaborative meetings and submitted proposals. The ICD team in WHO headquarters has received over 10 000 proposals for revisions.
ICD-11 will be presented at the World Health Assembly in May 2019 for adoption by Member States, and will come into effect on 1 January 2022. This release is an advance preview that will allow countries to plan how to use the new version, prepare translations, and train health professionals all over the country.
The ICD is also used by health insurers whose reimbursements depend on ICD coding; national health programme managers; data collection specialists; and others who track progress in global health and determine the allocation of health resources.
The new ICD-11 also reflects progress in medicine and advances in scientific understanding. For example, the codes relating to antimicrobial resistance are more closely in line with the Global
Antimicrobial Resistance Surveillance System (GLASS). ICD-11 is also able to better capture data regarding safety in healthcare, which means that unnecessary events that may harm health – such as unsafe workflows in hospitals – can be identified and reduced.
The new ICD also includes new chapters, one on traditional medicine: although millions of people use traditional medicine worldwide, it has never been classified in this system. Another new chapter on sexual health brings together conditions that were previously categorized in other ways (e.g. gender incongruence was listed under mental health conditions) or described differently. Gaming disorder has been added to the section on addictive disorders.
“A key principle in this revision was to simplify the coding structure and electronic tooling – this will allow health care professionals to more easily and completely record conditions,” says Dr Robert Jakob, Team Leader, Classifications Terminologies and Standards, WHO.
Dr Lubna Alansari, WHO’s Assistant Director-General for Health Metrics and Measurement, says: “ICD is a cornerstone of health information and ICD-11 will deliver an up-to-date view of the patterns of disease.”
ICD-11 is linked to the WHO non-proprietary names of pharmaceutical products, and it can be used for cancer registration. ICD-11 has been designed to be used in multiple languages: a central translation platform ensures that its features and outputs are available in all translated languages. Transition tables from and to ICD-10 support migration to ICD-11. WHO will support countries as they move towards implementation of the new ICD-11.